Pfizer

WASHINGTON — The Department of Health and Human Services announced last week that it has reached an agreement with Pfizer to ensure continued patient access to the antiviral Paxlovid as it prepares to transition the COVID treatment to the commercial... Read More

CAMBRIDGE, Mass. — Pharma giant Moderna sued Pfizer and BioNTech on Friday, claiming that their popular COVID vaccine was copied from groundbreaking science Moderna performed. In a statement posted on its website, Moderna said Pfizer and BioNTech infringed on patents... Read More

WASHINGTON — Pfizer and its German partner, BioNTech, asked the Food and Drug Administration Monday to authorize COVID booster shots that target the omicron BA.4 and BA.5 subvariants for people aged 12 and older. The request came less than a... Read More

Pfizer will spend about $5.4 billion to buy Global Blood Therapeutics as the pharmaceutical giant continues to invest some of the cash influx reaped during the COVID-19 pandemic. Pfizer said Monday that the acquisition will boost its capabilities in rare... Read More

WASHINGTON (AP) — U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. The long-awaited milestone comes as... Read More

JOHANNESBURG (AP) — The omicron variant appears to cause less severe disease than previous versions of the coronavirus, and the Pfizer vaccine seems to offer less defense against infection from it but still good protection from hospitalization, according to an analysis... Read More

Pfizer said Wednesday that a booster dose of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective. Pfizer and its partner BioNTech said that while two doses may not... Read More

WASHINGTON — Pfizer and BioNTech SE asked the Food and Drug Administration Tuesday to allow boosters of its COVID-19 vaccine for anyone 18 or older. Currently, COVID-19 booster shots are only available to older Americans and those with underlying health... Read More

Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 in what would be a major expansion that could combat an alarming rise in serious infections in youngsters and help schools... Read More

WASHINGTON (AP) — Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November. The company said Tuesday it provided health regulators... Read More

Pfizer is about to seek U.S. authorization for a third dose of its COVID-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant. Research from multiple... Read More

MISSION, Kan. (AP) — After more than a year of fretting over her 13-year son with a rare liver disease, Heather Ousley broke into tears when she learned that he and millions of other youngsters could soon be eligible for... Read More

Officials from the top U.S. pharmaceutical companies making the COVID-19 vaccine are saying vaccinated persons are likely to need booster shots within a year. In fact, they probably will need to get vaccinated yearly for the foreseeable future, similar to... Read More

Pharmceutical giant Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly, the White House announcedTuesday. The partnership will help advance the administration's goal of speeding up production... Read More

WASHINGTON - On Saturday, the Food and Drug Administration gave emergency authorization to a third coronavirus vaccine. This vaccine, unlike the Pfizer and Moderna vaccines which received emergency authorizations in December, is a single shot vaccine.  Placebo-controlled, randomized studies of... Read More

New research suggests that Pfizer’s COVID-19 vaccine can protect against a mutation found in two easier-to-spread variants of the coronavirus that erupted in Britain and South Africa. Those variants are causing global concern. They carry multiple mutations but share one... Read More

SACRAMENTO, Calif. – This week, California Gov. Gavin Newsom announced that the country’s largest and most populous state has opted in to the federal COVID-19 Pharmacy Partnership, providing no-cost Pfizer vaccines to residents and staff in long-term care facilities. At... Read More

Pfizer Inc. and BioNTech SE’s COVID-19 vaccine won the backing of the European medicines regulator, clearing the way for inoculations to start before the end of the year as the continent struggles with rising death rates and tighter lockdowns. The... Read More

WASHINGTON - High-ranking government officials, including House Speaker Nancy Pelosi, D-Calif., and Vice President Mike Pence, began receiving their first dose of the coronavirus vaccine Friday, part of an effort to ensure the continuity of the government and reassure hesitant... Read More

WASHINGTON - Under intense pressure from the White House, the Food and Drug Administration dramatically moved up its timeline, issuing an emergency authorization for Pfizer's COVID-19 vaccine on Friday. The agency had initially planned to finalize its authorization on Saturday,... Read More

WASHINGTON -- A federal panel of outside experts on Thursday endorsed a coronavirus vaccine from Pfizer and BioNTech, recommending that the Food and Drug Administration move forward with emergency authorization. President-elect Joe Biden responded with a statement saying, “Today’s approval... Read More

WASHINGTON — All Americans who want to get a COVID-19 vaccine should be able to do so by the second quarter of next year, Health and Human Services Alex Azar said. With the U.S. Food and Drug Administration due to decide as early as Thursday... Read More

Pfizer Inc. said a final analysis of clinical trial data showed its COVID-19 vaccine was 95% effective, paving the way for the company to apply this week for the first U.S. regulatory authorization for a coronavirus shot. The U.S. drugmaker and partner BioNTech SE said their vaccine... Read More

A COVID-19 vaccine from Pfizer Inc. may be on the horizon, but the cost of distributing vaccines across all 50 states and who will pay for that operation remains a huge stumbling block. What is clear is that much of the financial... Read More